ꓟꓬ-ꓟ ꓗꓴꓷꓼ ꓗꓪ ꓗꓳ-ꓪꓰꓼ ꓠꓻ ꓫꓬꓹ ꓠꓯ ꓞꓲꓼ (ꓜꓽ ꓓꓳ ꓓꓴ) ꓔꓯ ꓮꓮ ꓟꓰꓓꓲꓚꓮꓡ ꓡꓰ ꓫꓬꓹ ꓓꓳ ꓔꓸꓳ ꓐꓰ 2022 ꓘꓳꓼ 2 ꓦ 10 ꓠꓬꓲ ꓕꓯꓽ ꓢꓷ ꓙ ꓟꓴ ꓙ ꓩꓴ ꓡ ꓡꓳ꓿


ꓗꓳ-ꓪꓰꓼ ꓠꓻ ꓫꓬꓹ ꓠꓯ ꓞꓲꓼ ꓕꓱ ꓟ ꓠꓬ ꓟꓲ ꓠꓯ ꓗꓪ ꓬꓲꓸ ꓪꓴꓸ ꓓꓳ ꓡ ꓟ ꓜꓽ ꓓꓴ ꓠꓯ ꓞꓲꓼ ꓥ ꓢꓲ꓾ ꓴꓗ ꓗꓴꓷꓼ ꓗꓪ ꓟ ꓟꓧꓣꓮ ꓜꓴ ꓗꓪ ꓐꓰ ꓓꓽ ꓔꓳꓹ ꓔꓸ ꓟ꓾ ꓴꓢ ꓝꓓꓮ ꓗꓪ ꓐꓰ ꓠꓲꓹ ꓞ ꓠꓲꓹ ꓧꓳꓽ ꓣꓱꓽ ꓓ ꓟ ꓠꓯ ꓞꓲꓼ ꓥ ꓡꓳ ꓐꓯ ꓢꓲꓸ ꓓꓽ ꓔꓳꓹ ꓔꓸ ꓟ Molnupiravir ꓠꓯ ꓞꓲꓼ ꓔꓯ Pacific Medical Industries Ltd ꓡꓰ ꓟꓬ-ꓟ ꓗꓴꓷꓼ ꓗꓪ branded generic MOLNUPAC ꓟꓬꓱꓺ ꓖꓶ ꓔꓸ ꓟ꓾ Myanmar FDA ꓗꓪ ꓐꓰ ꓔꓳꓹ ꓙ ꓕꓳ ꓶ ( 2302ND002) ꓙꓳ,ˍ ꓟ ꓠꓯ ꓞꓲꓼ ꓥ ꓡꓳ꓾ ꓐꓰ ꓐꓯ ꓟꓳꓸ ꓖꓶ ꓔ ꓡꓳ꓿
ꓢꓳꓴꓣꓚꓰ: https://www.myanmaplatform.com/m/a/57820.htmlhttps://www.myanmaplatform.com/m/a/57820.html